Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban for Intrahepatic Non-Cirrhotic Portal Hypertension
NCT04007289Phase 3Active, not recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jun 2019
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of apixaban in idiopathic non-cirrhotic portal hypertension (IPH), sponsored by Assistance publique - Hôpitaux de Paris. Started Jun 2019; status: active, not recruiting.
02
Drugs
apixaban
03
Conditions
idiopathic non-cirrhotic portal hypertension (IPH)
Beyond the preview
Go deeper on NCT04007289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04007289.